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INTRODUCTION
1985 marks the bicentenary ofthe publication ofWilliam Withering's account ofhis
studies on the clinical use ofdigitalis.' The first part ofthe present article reviewsthe
use ofdigitalis before Withering and also the impact that his work had on the use of
digitalis in the next hundred years or so. The final two sections deal with work in the
present century concerning the clinical use of digitalis and also its mechanism of
action. It will become clear that, although an enormous amount of work has been
done since Withering, both the therapeutic use and the mode of action are still
controversial.
DIGITALIS BEFORE WITHERING'S MONOGRAPH IN 1785
Digitalispurpurea was so named in 1542 by Leonhard Fuchs. It wascertainly known
and used before the Withering monograph was published. Ointments containing
digitalis are mentioned in the Welsh pharmaceutical book Meddygon Myddmacn
around 1250, asbeinggoodforheadaches and spasms. Digitalispillsare describedin
Hieronymus Bock's Book ofherbs (1546). In England, digitalis was recommended
by John Parkinson (1567-1650) and William Salmon (1644-1713) for treatment of
epilepsy, goitre, and tuberculosis, and as an expectorant and an emetic. Salmon
published several works on medicinal plants and in one2 mentioned digitalis as
providing therapy for dropsy, a disease involving ageneralized accumulation offluid
now regarded as a symptom of heart failure. It was included in the Pharmacopoeia
Londinensis (1650).
However, before Withering's account, digitalis had fallen almost into disuse. This
was largely due to reports ofthe toxic nature ofthe drug when taken by mouth. For
example, Frangois Salerne in 1748 gave a lecture to the French Academy in Paris,
which seems to be the first account of animal experiments using digitalis.3 He
described how, after administering digitalis leaves to turkeys and roosters, the
animals appeared drunk, had fits, and died. He cautioned "on voit par ces
experiences le derangement que l'usage de cette plante peut causer dans les organes
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1 William Withering,An account ofthefoxgloveandsome ofitsmedical uses: withpracticalremarks on
dropsy and other diseases, Birmingham, 1785.
' W. Salmon, Botanologia: the English herbals; or history ofplants, London, 1710, p. 399.
3Fransois Salerne, 'Observation de botanique', Histories de l'Academie Royale des Sciences, Paris,
1748, pp. 120-122.
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de ces animaux". Shortly before, Herman Boerhaave (1668-1738) had considered
digitalis too toxic.4
WILLIAM WITHERING (1741-99)
William Withering (plate 1) was born in Wellington, Shropshire, the second child
and only son of Edmund and Sarah Withering. His father was an apothecary, who
also had private means from an inheritance and had married well, as Sarah was the
daughter and sister of physicians.5 After local schooling William went to medical
school in Edinburgh in 1762. He appears to have enjoyed Edinburgh, and read
papers to the student medical society, including one on dropsy. He received his
diploma in 1766, with a thesis dissertation on 'Malignant putrid sore throat'. After
spending a few months in Paris, and visiting his family in Wellington, he started
medical practice in Stafford, which is only about twenty miles from his home town.
At this time (1767), the Staffordshire Infirmary was started, with Withering and Dr
Archibald Campbell as the first two physicians. During his first year in Stafford,
Withering treated Miss Helena Cookes, an attorney's daughter. Helena drew and
painted flowers, and Withering started collecting specimens for her. They were
married in September 1772. Matrimony stimulated Withering to look for a practice
which would bring him more income. He left Stafford for Birmingham in 1775. His
practice at 9 Temple Row increased steadily in size to become one of the largest
outside London, producing an income of£2,000 per annum. He became one of the
most successful physiciansofhisday, treatingwell-to-do andtitledpeople alongwith
his free consultation periods for the poor. Forexample, Benjamin Franklin, when in
Paris, requested advice from Withering for treatment of a stone in the bladder.
Around this time (May 1776) Withering's two volumes entitled The botanical
arrangement ofallthe vegetables naturallygrowingin GreatBritain' were published.
Linnaeus had published his Genera et species plantarum in 1736, and Withering's
work wasthe firstcomprehensive English publication basedonthe Linnaean system.
Apparently, Withering thought that the terms used to describe the sexual
characteristics of plants, which form the basis of the Linnaean system, were too
explicit considering the manyladieswhowere attracted tobotany. He therefore used
the terms "pointal" for pistil and "chive" for stamen. Interestingly, Withering said
little about the medical attributes of plants, since he considered that too few facts
were available to warrant inclusion. Under foxglove, he said "a dram of it taken
internally excites violent vomiting. It is certainly a very active medicine and merits
more attention than modern practice bestows on it." Withering started collecting his
case histories for his account of the foxglove in 1775, i.e., just a year before these
volumes were published. It is probable that Withering considered these botanical
volumes his chief work. It was undoubtedly successful-a fourteenth edition
4 F.H. Garrison,An introduction to the history ofmedicine, Philadelphia and London, W.B. Saunders,
1929, pp. 315-317.
' T.W. Peck and K.D. Wilkinson, William Withering ofBirmingham. Bristol, John Wright, 1950. Fora
discussion ofthe social status ofapothecaries in eighteenth-century England, see J.G.L. Burnby,A study
ofthe English apothecary from 1660 to 1760, (Medical History, supplement no. 3), London, Wellcome
Institute for the History of Medicine, 1983, pp. 92-112.
6 William Withering, Thebotanical arrangement ofallthe vegetables naturallygrowingin GreatBritain,
Birmingham, 1776.
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appearing just overa hundred yearslater(1877). Hisreputation as abotanist spread
all over Europe and he wasmemberofthe Linnaean Society. The plant, Witheringia
solanacea, is named after him.
Withering had many other scientific interests. He was a scholar of geology,
presenting papers totheRoyal Society onrocksandsoil. Indeed, because ofhiswork
distinguishing bariumcarbonate from barytes(bariumsulphate), Werner, a German
chemist, in 1796 named barium carbonate asWitherite. Withering also analysedspa
water from various sources, including the famous hot springs at Caldas in Portugal,
forwhich he wasawardedhonorary membership ofthe RoyalAcademy ofPortugal.
Withering, whosufferedforalargepartofhislifefromconsumption, wasinPortugal
to escape the English winter and convalesce. At the age offifty-eight, on 6 October
1799, he died.
WITHERING AND THE FOXGLOVE
In 1775, Withering started collecting case histories on the effects of digitalis in
dropsy and ascites (accumulation offluid in the abdomen). But what had led him to
startusinginternalapplicationsofdigitalisatatime whenitwaslittleusedbecause of
reports of toxic effect? Withering himself explained this in his account.
In the year 1775, my opinion was asked concerning a family receipt for the cure ofdropsy. I was
told ithad longbeen kept a secret by anold woman inShropshire, who had sometimes madecures
after the more regular practitioners had failed and was informed that the effects produced were
violent vomiting and purging; for the diuretic effects seemed to have been overlooked. The
medicine was composed of 20 or more different herbs.
He examined the dried leaves microscopically. (His botanical volume contained an
account and a picture ofthe microscope he had designed forthe study ofbotany.) In
thisway,henotedthatthefoxgloveleafwaspresent,writing "Itwasnotverydifficult
for one conversant in these subjects, to perceive, that the active herb could be no
other than the foxglove". He determined, therefore, to investigate the effects of
digitalis. And he continued that, afternoting a fewcases, "I ventured to assert in the
Botanical Arrangement published the following spring that Digitalis purpurea
merited more attention than modern practice bestowed upon it". Withering made
notes on his animal experiments, for which, like Salerne, he chose the turkey. His
firstpatientswere thepoor, whocame foradvice duringhisone houradaywhichwas
free ofcharge. He observed the very powerful diuretic effect ofdigitalis, but added,
"I gave it in doses very much too large and urged itscontinuation too long". He said
that he did notintroduce itinto his more regularmode ofprescription until he heard
that Dr Crawley, the principal of Brasenose College, Oxford, had been cured of a
hydrops pectoris by foxglove root. Withering included in his account 163 cases he
had treated, plus others reported to him by physicians whom he had instructed in its
use. He reported all his cases, and so noted that digitalis did not successfully treat all
maladies involving accumulation offluid. The cases ofdropsy which he described as
having responded well to digitalis were those with the symptoms ofatrial fibrillation
with oedema. A distinction between dropsy from circulatory or kidney disease was
made later by Richard Bright (1789-1858).
Apart from these clinically important details, the most significant point in
Withering'sbook washisattention todosage. Sincethetherapeuticdoseofdigitalisis
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Plate 1. Portrait of William Withering. From an engraving of William Bond after a painting by Carl
Frederik von Breda (1792).Two hundred years ofthe foxglove
roundsixty percentofthe toxicdose,digitalishas one ofthelowestsafetymarginsfor
a prescribed drug. Withering's account gave details of when to collect the leaves,
noting that one could not trust the root of a biennial plant. He gave exact
measurements for making digitalis infusions, i.e., 1 dram of the dried leaf infused
with a half-pint ofboiling waterforfourhours and an ounce ofanyspiritousliquid to
be added. Thedosageforan adult was an ounce twicedaily. Witheringdevotedmany
pages to effects, rules, inferences, and cautions on the use of digitalis leaf. He
explained that there was no need to bring on sickness and purging, rather togive the
initial dose, wait long enough for it to take effect, and continue until it acted on the
kidneys, stomach, pulse, or the bowels; then let it be stopped upon the first
appearance ofany ofthese effects. Although undoubtedly Withering wasadvocating
digitalis because of its diuretic effect, he did draw attention to the cardiac action of
the drug. He noted how "attention to the state ofthe pulse" should be made and that
"it [digitalis] has a power overthe motion ofthe heart, to adegree yet unobserved in
any other medicine, and that this power may be converted to salutary ends". He
thought that slowing of the heart was as much a side-effect ofdigitalis as the nausea
and vomiting. He also stated that, "ifthe [patient's] pulse be feeble orintermitting"
the drug would effectively relieve dropsical symptoms. Withering's correspondence
with Hall Jackson in America demonstrates how cognizant he was of the action of
digitalis. In February 1786,7 HallJackson requested asupply offoxglove seeds asthe
plant was unknown in his vicinity (New Hampshire); in his reply, Withering
described how he had cured three cases of haemoptoe which "were the kind with a
quick-bounding pulse and I directed the medicine [digitalis] from the quality I knew
it possessed ofabating the action ofthe heart". No othermanuscript from Withering
on thissubject is known. It seems, therefore, that we must conclude that Withering's
most important contributions on digitalis were to revive interest in the drug and lay
down guidelines for dosage and treatment. It is worth remembering that before
Withering's account, dropsy was almost always a fatal disease.
DIGITALIS AFTER WITHERING S ACCOUNT
Withering's writing undoubtedly sufficiently stimulated physicians ofthe time to try
digitalis asacurefordropsy. The mostpublicized report wasthat ofDrJohn Coakley
Lettsom (1744-1815). In 1773, at the age of twenty-nine Lettsom had founded the
Medical Society of London and had been elected to the Royal Society. In 1788, he
published the results of his own unsuccessful experiences with digitalis.8 Among
Lettsom's eight patients was Charles James Fox, the statesman, who was suffering
from cirrhosis, and in whom digitalis apparently provedfatal.8 Withering pointed out
to Lettsom that he used both too large a dosage and did not choose those with
"constitutions favourable to the drug".9 There does not, however, appear to have
been any animosity between the two men, since Lettsom wrote to Withering inviting
him to become a provincial member of the Medical Society of London. Withering
7 J. Worth Estes, HallJackson and thepurplefoxglove, Hanover, New Hampshire, University Press of
New England, 1979, p. 207.
8 John Coakley Lettsom, 'Ofthe digitalispurpurea, in hydropicdiseases', Mem. Med. Soc. Lond., 1794,
2: 145-180.
Peck and Wilkinson, op. cit., note 5 above, pp. 82-83.
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accepted and received his diploma of the society in 1787. Sir George Baker
(1722-1809), a physician to King George III, reported a case ofthe successful use of
digitalis in dropsy. Physicians in Withering's vicinity (Birmingham) were also
reporting their experiences with digitalis. The surgeon William Jones noted that the
foxglove reduced the pulse in his patients, and a Mr Mynors (another Birmingham
surgeon) recommended it "with a view to diminish the increased action ofthe heart,
and the whole of the vascular system"."0 Thus it is possible that Withering and
Birmingham's doctors were coming to think more of digitalis acting on the heart.
Tangential evidence is supplied in a poem about the drug, written by Miss Sarah
Hoare (1767-1855) in 1818. Miss Hoare's father hadbeen treated with digitalis, for
congestive heart failure.
TheFoxglove'sleaves, withcautiongiven,
Another proof of favouring Heav'n,
Will happily display;
The rapid pulse it can abate;
The hectic pulse it can moderate;
And blest by Him whose will is fate,
May give a lengthened day.
With, ormoreprobablywithout, understanding thebasicaction ofdigitalis,clinicians
were gaining experience with it as a result of Withering's work. After Withering's
publication, the first attempt to see how digitalis affects the body appears to be that
undertaken by Thomas Beddoes (1760-1808) and his surgical colleague, Mr King.
Beddoes published a report in 1794, demonstrating that opium counteracted
digitalis toxicity.11 He performed experiments on frogs and toads, applying digitalis
to the skin, and observed initial excitement followed by inactivity. From these
observations and his clinical experience, Beddoes concluded that digitalis would
increase the action of the arterial system and that it increased the organic action of
the contractile fibres as much or more than opium. There was much debate at this
time as to whetherdigitalis was a sedative, inducing sleep and diminishing the pulse,
or a stimulant, producing diuresis and purging.
John Ferriar(1761-1815) recognizedthatdigitalis'sprimaryaction isontheheart.
Ferriar, another Edinburgh graduate and a Manchester physician, in a monograph
on digitalis in 1799,12 reported how the foxglove retards the velocity of the pulse,
reducing it, "without danger from 120 in a minute to 75 or 80". He said what great
difficulty there is"respecting thetheory ofthe action ofdigitalis . . . " andthat"Ifeel
it impossible to explain this phenomenon at present. The diuretic power of digitalis
does not appear to me a constant and essential quality of the plant; the power of
reducing the pulse is its true characteristic." He continued "the secreting vessels of
the kidnies are, in general, affected by stimulants, which act upon the whole of the
Estes, op. cit., note 7 above, p. 172.
1 T. Beddoes, 'An account of the good effects ofopium in the case of a person poisoned by digitalis',
Medical Facts and Observations, 1794, 5: 17-20.
12 John Ferriar, An essay on the medical properties ofthe digitalis purpurea orfoxglove, Manchester,
1799, p. 4.
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blood-vessels; but it is conceivable, that a spasmodic state of the vessels secreting
urine, or a diseased action in them may be overcome by aremedy, which lessens the
force of the general circulation."And again, "I have had occasion to mention,
formerly, the utility of digitalis in palpitations of the heart and have known it to
remove the complaint entirely . . . even in cases depending on organiclaesions ofthe
heart... and rendered life not only longer, but more supportable... and in one
remarkable case of [ofdropsy] ... the vigour and steadiness ofthe pulse increased,
exactly in proportion as the water was withdrawn from the cellular membrane."
As an index of the interest and knowledge of digitalis, the Medical and Physical
JournalofLondon, vol. 3 in 1800, had nine papers on the foxglove. Medical writers
were taking account ofdigitalis. Thus John Murray wrote in his textbook ofmateria
medica (1804), "of all narcotics, digitalis is that which diminishes most powerfully
the action ofthe system; anditdoessowithoutoccasioning anypreviousexcitement.
Eveninthe mostmoderatedoseitdiminishestheforce andfrequencyofthepulse ...
it is one of the most certain diuretics in dropsy apparently from its power of
promoting absorption.""3 Kreysig of Saxony in 1814, also postulated a direct effect
ofdigitalis on the heart and blood vessels. However, he assumed that the slowing of
the pulse originated in the brain. Johann Evangelista Purkinje (1787-1869),
Professor of physiology at Breslau and Prague, described arrhythmias and optical
sensation upon the self-administration of foxglove leaves.
An assessment of Withering's publication thirty years on is provided by Dr. John
Blackall (1771-1860), who published his own observations on patients with dropsy,
including the fact that there is often albumin in the urine."4 He stated "This plant
[foxglove] hascertainly made agreataddition oflate yearsto ourmeansofcure. For
although before the time of Dr. Withering's publication on that subject it has been
employed very frequently both in this and other countries as a domesticdrug, yet its
exhibition was regulated by no sort of principle or distinction and accuracy, as to
dose, was wholly out of the question."
The story of digitalis now turns partly into one of declining use. For reasons that
are not entirely clear, digitalis became less favoured clinically, although
experimental observation continued to be made. One explanation for the decline in
clinical usage ofdigitalis given by Holmstedt and Liljestrandis "thegeneral nihilistic
view of therapeutics" which prevailed in the nineteenth century.15 Estes suggests
thai, because clinicians at that time believed that dropsy and consumption had very
similar pathologies, and consumptives were treated with foxgloves with
disappointing results, then faith in digitalis to cure dropsy was shaken.16 This
suggestion is amplified by Ackerknecht, who notes how new drugs, such as digitalis,
quinine, and iodine, quickly come to be regarded aspanaceas.17 As digitalis became
used far more often for conditions it could not improve (fevers, epilespsy, scrofula,
goitre, nymphomania), this led to scepticism about its use for any condition.
13 John Murray, Elements ofmateria medica andpharmacy, Edinburgh, A. Neill, 1804, pp. 131-300. 14 JohnBlackall,Observations onthenatureandcureofdropsies, London, LongmanHurst, Rees, Orme
& Brown, 1818, pp. 300-302.
15 B. Holmstedt and G. Liljestrand, Readings inpharmacology, Oxford, Pergamon Press, 1963, p. 57.
16 Estes, op. cit., note 7 above, p. 231.
17 Erwin H. Ackerknecht, 'Aspects ofthe history oftherapeutics', Bull. Hist. Med., 1962 36: 389-419.
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Influential physicians, for example Corvisart (1755-1821) and his pupil Laennec
(1781-1826), both dismissed digitalis. Clinicians were also starting to forget
Withering's insistence on small doses and thus eliciting toxic effects with the drug.
Jawetz has postulated that all drugs go through an initial period of "enthusiasm",
followed by "disappointment" and then a "final stabilization"."8 In the nineteenth
century, speaking in general terms, digitalis was definitely in the "disappointment"
phase, although important experimental observations were made. Jean-Baptiste
Bouillaud (1796-1881) published his Traits clinique desmaladies du coeur based on
auscultation in 1835.19 He described digitalis as "le grand moderateur, cette sort
d'opium ducoeur". LudwigTraube(1818-76) was apupil ofPurkinje and aclinician
in Berlin, who has been credited with imparting new momentum to the study of
digitalis. By 1850, he had recognized the increase in efficiency of cardiac muscle
under the influence of digitalis. He further suggested that the digitalis-induced
bradycardia (slowing of the heart) was a result of vagal stimulation. In 1854,
Homolle and Querenne published their effort to make purer extracts of digitalis.20
Vulpian, in 1855, was the first to use animal experiments to elucidate the action of
digitalis, rather than just to observe the symptoms induced. Infrog heart, he showed
a slowing of the auricles and muscular contracture of the ventricles. However, the
notion that digitalis must act as a "sedative" still persisted, making it difficult to
understand itstherapeutic value. Then, in 1870, G.W. Balfour ofEdinburgh argued
thatdigitalis strengthened the heart and thatitsaction could notbeentirelysedative.
Milner Fothergill, the next year, said "increasedventricular contraction isthe action
parexcellence ofdigitalis".21 Diuresis in clinical cases he ascribed to an amelioration
ofthe condition of the circulation. By the beginning of the twentieth century, Elijah
Houghtonhadintroduced thestandardization ofdigitalispreparations inthefrog. At
the end of the nineteenth century, the direct effect of cardiac glycosides (a name
given by Gerhardt in 1852) on cardiac contractility was still being overlooked by
manyinvestigators, whowere moreconcerned with alterations ofrhythm, role ofthe
vagus, and the systoliccontracture seen in amphibian hearts. Butit wasthen realized
that the heart was the site of digitalis action and the diuresis was a secondary effect.
Purer forms of digotoxin were also made. As an example of thinking on digitalis in
the 1880s, Karl Binz's (1832-1912) lecture notes of 1884 can be consulted.22 Binz
stated that the force of a single contraction of the ventricle can be four to six times
greaterthan normal in digitalis-treated animals. He said how LudwigTraube referred
to thisincreased action being due tostimulation oftheexcito-motor nerves, butBinz
made the salient point that the result is essentially the same in an isolated heart. He
continued, "we know now that digitalis chiefly acts, not by lowering the action ofthe
heart, but by regulating and strengthening it, and that consequently the diminished
frequency of the pulse is only a symptom of minor importance." The differential
1 Ernest Jawetz, 'Infectious diseases: problems of antimicrobial therapy', Ann.Rev.Med., 1954, 5:
1-26.
19 J.-B. Bouillaud, Traite clinique des maladies du coeur, Paris, 1835. 20 E. Homolle and T.A. Querenne, Memoire sur la digitaline et la digitale, Paris, 1854. 21 J.M. Fothergill, Digitalis: its mode ofaction, London, 1871. 2 Karl Binz,Lecturesonpharmacologyforpractitionersandstudents, London, NewSydenham Society,
1895, vol. 154, pp. 242-260.
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effect on dropsy due to heart and kidneydisease wasalso knownby then. "The effect
which digitalis has of equalising the circulation and of removing a state of passive
congestion of the kidneys is an important indication for its use as a diuretic. It only
acts assuch in those casesin which the decrease ofthe urine, and thedropsy; depend
on some heart mischief. Digitalis has no direct action upon the kidney tissue."
Incontrasttotheinterestinthe mechanism ofaction ofdigitalis, itstherapeuticuse
had not advanced during the nineteenth century. This caused Cushny to write in
1922, "what was written by its [digitalis] advocates in 1810 might have been quoted
as representing the general view in 1900. Those who wish to follow the sterile
discussions of this period will find some account of them in Meyer's
'Digitalistherapie' ", and "the physician... continued to prescribe digitalis in
disease of the heart after the manner of his father and perhaps with less
discrimination than his grandfather."23
CLINICAL USE OF DIGITALIS IN THE TWENTIETH CENTURY
By the beginningofthe twentieth century, digitalis wasestablished asthe mainstay of
the treatment ofcardiacfailure. Its use for most ofthe otherdiseasesforwhichit had
been promoted during the nineteenth century had been discarded. Changes in the
clinical usage ofdigitalis during the present century have been relatively modest and
the purified active principle from digitalis is still used, or at least given a trial, in
virtually all cases of heart failure. Because cardiac failure is a common disease and
because a cardiac glycoside is often prescribed indefinitely, the cardiac glycosides
have become the fourth in the list of most commonly prescribed drugs in the US.'
Formulation ofdigitalis products
During this century, substantial progress has been made in the formulation of
digitalisproducts. Witheringtried avarietyofdifferentwaysofextractingandstoring
the active principle and finally made the greatest use of the alcoholic extract or
tincture. At the beginning of this century, this practice was gradually being
superseded by the use of pills made from powdered digitalis leaf. Naturally, the
potency of such tinctures and pills showed great variations, and this meant that the
correct dose had to be found by experiment in every patient and that the process had
to be repeated whenever one batch ofpills or tincture was consumed. An important
development, therefore, was the introduction of biological standardization
procedures by Houghton in 1886.25 Hisprocedure involved theinjection ofgradually
increasing doses of digitalis into the lymph sac of a frog. The smallest dose which
arrested the heart under specified conditions was called afrog-unit. Thisunit proved
rather variable, and the seasonal nature of frogs caused problems, so that a more
satisfactory cat-unit wassoon introduced.26 Pharmaceutical houseswere quick to see
the advantages of these procedures and were soon marketing products which had
been standardized to contain a specified number of cat-units.
3 Arthur R. Cushny, The action and uses in medicine ofdigitalis and its allies, London, Longmans,
Green, 1925, p. 208.
'4 D. Schick and J. Scheuer, 'Current concepts of therapy with digitalis glycosides', Amer. Heart J.,
1974, 87: 253-258.
25 E. Houghton, 'The pharmacologia assay of heart tonics', J.Amer.Med.Ass., 1898, 31: 959-961.
6 See discussion in Cushny, op. cit., note 23 above.
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Active efforts were madethroughoutthe nineteenth century toobtainthepurified
active ingredients of digitalis extracts. Although Homolle and Querenne won the
prize of 1000 francs offered by the Societe de Pharmacie in 1845 for the production
ofa purified crystalline extract which they called digitaline,27 Cushny in 1904 stated
"digitaline ofcommerce varies much incomposition and indose, sometimesproving
entirely inert, while at other times it has proved poisonous in comparatively small
quantities".'8 Not until the 1920s and '30s did the purified preparations ofthe main
active ingredients, digoxin and digitoxin, become available in a sufficiently reliable
form for them gradually to supersede the cruder extracts. Digoxin anddigitoxin are
now the main products used and they are available in sufficient purity to have
obviated the need for biological assay. Nevertheless, they are still extracted from
foxglove leaves. In the last decade, it has also become possible to measure serum
levelseasily andcheaply, andthishasledto a betterunderstanding oftheabsorption,
metabolism, and excretion without, however, leading to any pronouncedchanges in
clinical practice.29
The value ofcardiac glycosides forpatients in sinus rhythm
Although the indications for the use of cardiac glycosides have not, in fact,
changed dramatically during this century, there have been many investigations and
muchdebateparticularly onthequestion ofthevalueofcardiacglycosidesinpatients
with cardiac failure who are in sinus rhythm. Research in this area has been
stimulated by a rapid increase in the understanding of cardiac arrhythmias,
particularly at the turn of the century when the electrocardiograph was developed30
and introduced to clinical practice.31 In addition, the gradual development of the
clinical trial has offered an objective means of assessing the relative values of
different drug treatments or of assessing the relative value of the same drug
treatments but in differing clincial situations.
The first edition of Cushny's Textbook ofpharmacology (1904) described the
major therapeutic value of digitalis as "counteracting certain changes in the
circulation which resultin bloodaccumulating inthe veinsin largequantities".32 The
mechanism ofaction ofthe drugwasthe "increasedcontraction oftheventricles and
auricles in systole". This view is backed by a number of original records of
contraction offrog and doghearts (e.g., fig. 1) undertheinfluence ofdigitalisandby
an extensive bibliography. Cushny's views on the indications for glycosides and the
mechanism ofaction are suprisingly similar to those current today. He was adamant
that the beneficial effects ofdigitalis were not directly attributable to the slowing of
the heart, on the grounds that drugs which simply slowed the heart by an action on
the vagus had no such beneficial effect. This is in direct contrast to the ideas
promulgated several decadeslater byThomas Lewis, whopersistently, butwith little
S7 Homolle and Querenne, op. cit., note 20 above.
A.R. Cushny,Atextbookofpharmacologyandtherapeutics, 3rded.,London, Rebman, 1904,p. 456.
9 Schick and Scheuer, op. cit., noe 24 above.
30 W. Einthoven, 'Uber die Deutung des Electrocardiograms', Pflugers Arch. ges. Physiol., 1913, 149:
65-86.
3 Thomas Lewis, Lectures on the heart, New York, Hoeber, 1915. 32 Cushny, op. cit., note 28 above, pp. 457-458.
33 Thomas Lewis, Diseases ofthe heart, London, Macmillan, 1933, pp. 86-87.
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a b c
Figure 1. The effects of digitalis on intraventricular pressure in a dog heart. Panel a shows a control
record whileb andc were obtained after infusingdigitalis. The record isreproduced from Cushny(opcit.,
footnote 23, p. 100) and was originally obtained by Francois Franck in 1894.
evidence, maintained that the main value ofglycosides was to rest the heart during
the diastolic period.33
In the first edition of his book, Cushny made no special claims for digitalis in the
various types of cardiac failure which were recognized at that time. However, the
situation changed quickly when atrial (or auricular) fibrillation was recognized
clinically by various figures at the beginning of the century34 and confirmed with
electrocardiographic evidence by Lewis (1912).35 Atrial fibrillation was shown to
complicate 60-70 percentofthecasesofcardiacfailurepresenting atthattime.Thus,
in 1910, Wenckebach gave the following vivid account of the value of digitalis.36
Amongthe drugsusedfor manyyears there isnone perhaps more relied upon, morerightly trusted
to, than digitalis. No practitioner ever failed to see its marvellous effects in appropriate cases....
What everyone knows about digitalis is, that in cases of heart failure with a small and weak pulse,
quick and irregular rhythm, with dilation of its chambers, overfilling of the veins, dysuria and
dropsy, it works wonderfully, slows and steadies the heart, raises the blood pressure, aids diuresis
and drains the dropsical limbs. We know that in some cases, not well defined yet, it loses its
beneficial effects, or even may do harm; that in large doses or if given for too long a time it
accumulates in the body and causes symptoms of poisoning. So we give it as Withering did 125
years ago, until adesirable effect isreached, certainly stopitassoon asanyinconvenience ofits use
might appear.
This is a clear expression of the view that digitalis is most effective in patients with
atrial fibrillation (fast, irregular pulse). Wenckebach also introduced the idea, which
hasstimulated muchresearch inthiscentury, thatitshould bepossibletodefine more
closely the categories of patients for whom the cardiac glycosides are relatively
effective and ineffective.
The careful case studies of Mackenzie, published in the same year as
Wenckebach's paper, also led to the conclusion that digitalis was much more
effective in heartfailure with atrialfibrillation thanwhensinusrhythmwaspresent.37
Mackenzie found that cases of heart failure who were in normal rhythm generally
had relatively mild symptoms, responded well to bed rest, and showed little if any
response to digitalis. It may be that the mild degree of failure in those with sinus
rhythm in his study disguised any benefical effect of digitalis. Mackenzie's findings
3 A.R. Cushny and C.W. Edmunds, Paroxysmal irregularity ofthe heart and auricular fibrillation,
Studies in Pathology, Aberdeen University, 1912, pp. 95-1 10.
'5 T. Lewis, 'Evidence of auricular fibrillation treated historically', Br. med. J., 1912, i: 57-60.
36K.F. Wenckebach, 'Discussion on the effects of digitalis on the human heat', ibid., 1910, ii:
1600-1610.
3 James Mackenzie, 'Digitalis', Heart, 1911, 2: 273-386.
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led him to the view that the rapid ventricular rate was a major factor causing heart
failure. Lewis endorsed thisview, stating "Those who regarded digitalis as a cardiac
stimulant mistake its character: its chief action is to rest the heart. To the heart the
foxgloveisnotatonicbutpowerfullyhypnotic. Itcontrolsthediastolesoftheheart,it
extends the period ofsleep."38 Theviewthatdigitalis haslittle value inthe treatment
of heart failure in sinus rhythm appears in the influential textbooks of Mackenzie
(1916)39 and Lewis (1933).4° Why these two central figures in British cardiology
chose to ignore the mounting evidence which contradicted this view is not entirely
clear. McMichael points out that by this time both were moving into different fields
and their interest in the recent advances in cardiology seemed to have been in
decline." Evidence foraneffective action ofcardiacglycosidesincardiacfailure with
sinus rhythm had been demonstrated in many studies, e.g. Janeway (1913),42
Christian (1921)," Luten (1924)," and Marvin(1927).45 Many ofthe earlierstudies
were reviewed by Gavey and Parkinson (1939),46 and their own results were typical.
They compared the responses to digitalis of two groups of patients in heart failure,
forty-seven with sinus rhythm and thirty with atrial fibrillation. Cardiac failure was
diagnosed on the basis of dyspnoea, liver enlargement, pleural effusions, and
peripheral oedema, and improvement with digitalis was assessed by regression of
these symptoms and signs. Both groups showed comparable improvement in a
preliminary period ofbed rest. Onsubsequenttreatmentwith digitalis, 60 percentof
the patients with sinus rhythm improved while 72 per cent with atrial fibrillation
improved. However, the proportion of patients showing "great improvement" was
only 12 percentinsinusrhythm but 28 percentin atrialfibrillation. Thus,theirstudy
shows both that digitalis has a substantial beneficial effect in sinus rhythm but that
the response in atrial fibrillation is greater. Note that there are substantial numbers
of patients in both groups who do not appear to respond.
The debate about the role ofcardiacglycosidesin heartfailure with sinusrhythm is
still unresolved.47 Every authority recommends glycosides in heart failure when
atrial fibrillation is present. There is much more variability in the recommendations
for patients with failure who are in sinus rhythm. Many authorities make no
distinction on the basis of the cardiac rhythm e.g., Goodman and Gilman,48 Hurst.49
38 Thomas Lewis, 'On the cardinal principles in cardiological practice', Br.med.J., 1919, ii: 621-625.
39 Sir James Mackenzie, Principles ofdiagnosis and treatment in the heart affections, London, Frowde,
Hodder & Stoughton, 1916, p. 240.
40 Lewis, op. cit., note 31 above, p. 32.
41 Sir John McMichael, A transition in cardiology: the Mackenzie Lewis era. Harveian Oration 1975,
London, Royal College of Physicians, 1976.
42 T.C. Janeway, Trans. 17th Internat. Congress Medicine, London, 1913.
H.A. Christian, 'Digitalis effects in chronic cardiac cases with regular rhythm in contrast to auricular
fibrillation', Med. Clin. N. Amer., Phila., 1921/22, 5: 1173-1190.
44 D. Luten, 'Clinical studies with digitalis', Arch. int. Med., 1924, 33: 257-278.
H.M. Marvin, 'Digitalis and diuretics in heart failure with regular rhythm, with special reference to
the importance of etiological classification of heart disease', J.cin.Invest., 1927, 3: 521-539.
46 C.J. Gavey and John Parkinson, 'Digitalis in heart failure with normal rhythm', Br. HeartJ., 1939, 1:
27-44.
4 A. Guz and D. McHaffie, 'The use of cardiac glycosides in sinus rhythm', Clin. Sci. & Mol. Med.,
1978, 55: 417-421.
48 L.S. Goodman and A. Gilman, The pharmacological basis of therapeutics, 5th ed., New York,
Macmillan, 1975, p. 676.
J.W. Hurst, The heart, 5th Ed., New York, McGraw-Hill, 1982.
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Others recommend diuretics asthe first line oftreatment and acardiacglycoside as a
second, e.g. HamerP This view reflects the fact that diuretics invariably reduce
oedema and are relatively free ofserious side-effects whereas the cardiacglycosides
are not uniformly effective and the side-effects are undeniably frequent and can be
life-threatening. Uncertainty about the value of glycosides is often resolved by
recommending a trial ofdigitalis and maintaining it only in those patientswho show
clear benefit.
The long-term value ofcardiac glycosides
A subsidiary argument has developed on the question ofwhether digitalis should
be maintained in the long term. In the past, it has been standard teaching that where
digitalis has been effective in the treatment ofchronic heart failure then it should be
continued indefinitely.5" This view was questioned by Gold, who suggested that
"only about 15% ofcardiac patients owe to the habitual use ofdigitalis the fact that
they are able to carry on with a reasonable degree of comfort".52 This provoked a
short but convincing study by Rogen, who withdrew digitalis from twenty patients
with established but controlled failure.53 Sixteen of these showed objective signs of
increasing failure (oedema, cyanosis, tachycardia, or visible dyspnoea), which
appeared on average afterfive weeks. Theremainingfourshowedsubjectivesignsof
increased failure (fatigue, dyspnoea on exercise) and were given a placebo. Their
symptoms did not respond to the placebo and all four subsequently developed
objectivesigns.Thuseverypatienteventually relapsed. However, allbuttwoofthese
patients had atrial fibrillation, so that this study confirmed the value of long-term
digitalis therapy in atrial fibrillation but did not address the issue for patients with
sinus rhythm.
Studies in the last decade have increasingly questioned the value of long-term
glycoside therapy for patients in sinus rhythm. A trial by Fleg et al. examined this
issue using the full range of modern clinical trial techniques.54 Thirty patients with
established heart failure who were in sinus rhythm entered the trial. At entry all
patients were on maintenance glycoside therapy -and the majority were using a
diuretic. The presence of compensated heart failure was established from clinical
symptoms, limitation of exercise capacity, and investigations of cardiac function.
Then for a three-month period the digitalis was either replaced by a placebo or
continued at the original dose, though neither the patients nor the doctors directly
involved knew which category particular patients belonged to. The other
medications were not changed during this period. In a second three-month period,
the placebo andthedigitaliswerereversed. Thegeneral resultwasthatwithdrawal of
digitalis had no significant effect on symptoms or exercise tolerance though some
50 John Hamer, 'The modern management of congestive heart failure', in D.J. Rowlands (editor),
Recent advances in cardiology, London, Churchill Livingstone, 1984, vol. 9, pp. 275-288.
5 Guz and McHaffie, op. cit., note 47 above.
52 H. Gold, 'Digitalis, its action and usage', Med.Ann.DC, 1941, 10: 127-133.
3 A.S. Rogen, 'Maintenance treatment with digitalis', Br.med.J., 1943, fi: 694-695.
J.L. Fleg, S.H. Gottlieb, and E.G. Lakatta, 'Is digoxin really important in treatment ofcomplicated
heart failure. Aplacebo-controlled crossover studyofpatientswith sinusrhythm',Amer.J.Med., 1982,73:
244-250.
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measures of cardiac function showed small but significant deterioration when
digitalis was withdrawn.
However, other trials on this issue have given more complicated results. Griffiths
et al. studied eleven patients in heart failure who were in sinus rhythm.55 When
cardiac glycosides were stopped, one patient showed a pronounced deterioration
which rapidly responded to restarting the glycosides: the others were unaffected.
These authors reviewed trials on thisquestion and noted that in 341 patientsfrom 10
trials, 16 per cent deteriorated on stopping long-term glycoside treatment. Thus,
while many patients can obviously manage withoutglycosides, there appears to exist
aminority whodobenefitinthelongterm.Thecharacteristics ofthisgroupremain to
be defined; conceivably, they are simply those with the most serious underlying
pathology. Griffiths et al. also made the point that most of the trials have shown
significant deterioration of cardiac function but this was often unaccompanied by
changes in clinical symptoms or signs. The explanation for thisfinding may rest with
the observation that, while cardiac glycosides increase the inotropic state in the
presence or absence of cardiac failure, the glycosides only augment cardiac output
when cardiacfailure is present. Presumably, cardiacoutputisnormally controlled by
homeostatic mechanisms and provided cardiac output is within the normal range, an
increase in inotropic state produced by a drug is counteracted by a reduction in
sympathetic drive.
RESEARCH ON THE MECHANISM OF ACTION OF DIGITALIS IN THE TWENTIETH CENTURY
Before describing more recent ideas on the mechanism of action of digitalis it is
necessary to review current ideas concerning the mechanism of contraction of
cardiac muscle. Contraction in cardiac muscle depends ultimately on the relative
movements of two proteins: actin and myosin. Energy for this is provided by the
hydrolysis of adenosine triphosphate (ATP). The principal signal which activates
contraction is a rise of the intracellular calcium concentration ([Ca2+]i) from about
0.1 to 5 ,tM and therefore the regulation of the contraction of cardiac muscle
depends primarily on theregulation of[Ca2+]j. Itisgenerallythought that,duringthe
heartbeat, the calcium required for contraction is released from an intracellular
store, the sarcoplasmic reticulum (s.r.). Relaxation of the heart is produced by the
reuptake ofCaions back into the s.r. The amount ofcalciuminthe s.r. andultimately
therefore the amount thatcan bereleased to activate contraction dependson [Cal+]i,
which is much less than extracellular calcium concentration. This concentration
gradient produces a passive influx of Ca ions into the cell, which is opposed by an
active extrusion ofCa ions. One mechanism for producing this isthe sodium-calcium
(Na-Ca) exchange, which uses the energy provided by Na ions entering the cell down
their electrochemical gradient to expel the Ca ions from the cell. Consequently, the
level of[Ca2+]i and ultimately force will depend on the transmembrane Na gradient.
The intracellular Na concentration is normally maintained at a low level by the
sodium-potassium (Na-K) pump and therefore anything which affects the activity of
this pump will ultimately affect contraction.
55 B.E. Griffiths, W.J. Penny, M.J. Lewis, and A.H. Henderson, 'Maintenance ofthe inotropic effect of
digoxin on long-term treatment', Br.med.J., 1982, 284: 1819-1822.
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As mentioned above, by 1900, it had been shown thatdigitalis could increase the
force ofcontraction ofthe isolated heart. Itwas not,however, until 1938 thatCattell
and Gold showed thatouabain could increase the force ofcontraction ofanisolated,
electrically stimulated, cat papillary muscle.56 One oftheirrecords isshown infig. 2.
As they pointed out, this experiment eliminated problems present in whole-heart
studies where it was difficult to control for effects on coronary blood flow, cardiac
size, and heart rate. Work in the twentieth century has therefore turned to the
mechanism of the increased cardiac contractility.
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Figure 2. The effects of ouabain on an isolated cat papillary muscle. The downward deflections show
the contractions of the muscle elicited by electrical stimulation at the times indicated. Note that, after
beginning the experiment, the developed force gradually fell spontaneously. The addition ofouabain (at
11:34) produced an increase of tension which eventually decayed away as the toxic effects of the drug
developed.Record taken from Cattell and Gold (1938), see footnote 56.
In 1910, Straub suggested thatdigitalisactedasasurface active agentandthatthis
reduction of surface tension somehow improved the contractility of the heart.57
However, Clark showed that substances which had much stronger surface-active
properties did not increase the force ofcontraction ofthe heart.58 Instead, he noted
that the actions of strophanthin are similar to those alkalis. Daly and Clark
commented thattheeffectsofdigitaliscouldbemimickedbyperfusingtheheartwith
a solution of reduced sodium content.59 This observation accords well with modern
ideasthat theprimary action ofdigitalisistodecrease thetransmembranegradientof
Naions(seebelow) but, atthetime, therewasnoexplanation oftheresult. Itwasalso
noted that the effects of digitalis depended on the presence of calcium in the
perfusing solution, and both Burridge' and Loewillsuggested that Caionsmight be
" M. Cattell and H. Gold, 'The influence of digitalis glycosides on the force of contraction of
mammalian cardiac muscle', J.Pharmacol.exp.Ther., 1938, 515: 221-235.
5 W. Straub, 'Quantitative Untersuchungen uber den Chemismus der Strophanthinwirkung',
Biochem.Zt., 1910, 28: 392-406.
5 A.J. Clark, 'The modeofactionofstrophanthinuponcardiactissue',J.Pharmacol.exp. Ther., 1914,5:
215-234.
59I. de B. Daly and A.J. Clark, 'Theactionofions upon thefrog'sheart',j. Physiol., 1921,54:367-383.
6° W. Burridge, 'Researches on the perfused heart, somefactorsofthe cardiacmechanism illustrated by
reference to certain actions of barium and digitalis', Quart.J.Med., 1915, 43: 271.
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involvedintheeffects ofdigitalis and,inparticular, thatglycosidesmight activate the
calcium of the heart or sensitize the muscle to calcium. In the light of subsequent
workwhich showedtheimportance ofcalciumin musclecontraction, thisviewseems
far-sighted. Itshould, however, be notedthatitwasbased onlittleotherthanthefact
that both calcium and digitalis increase contraction. It is, therefore, easy to
understand Cushny, who described this as a "shadowy thesis".6"
Since 1930, many hypotheses have been produced forthe mechanism ofaction of
the cardiac glycosides, a result of the explosion of work on cell biochemistry
and physiology during this period. Indeed, at one time or another, digitalis has been
suggested as affecting most stages in the mechanism ofcardiac contraction. We will
now review some ofthe suggested mechanisms. (i) Much work had been performed
on the control of metabolism and cellular respiration, and it was suggested that the
glycosides mightactbyaffectingthe energymetabolismofcardiacmuscle. Insupport
of this hypothesis, it was found that the concentrations ofvarious metabolites were
affected by digitalis. However, it was impossible to exclude the possibility that this
was secondary to some other effect rather than being the cause of the positive
inotropic action. Certainly, no effect of digitalis could be found on either isolated
mitochondria orenzymes.63 (ii) It was suggested that cardiacglycosides might act by
affecting the contractile proteins directly. Robb and Mallov showed that ouabain
increased the shortening of actomyosin which was produced by ATP.M Subsequent
workevenfoundthattheeffectsofvariousglycosidesonthethixotropy(thedecrease
of viscosity produced by stirring) of cardiac actomyosin correlated with their
biological potency.' However, this observation has not been confirmed, and this
explanation has fallen into disrepute. (iii) The intracellular ionic concentrations of
muscle cells are very different from those in the surrounding plasma and, in
particular, the intracellular concentrations of Na and K are respectively less and
greater than those in plasma. It was, therefore, of interest to see whether cardiac
glycosides affected the intracellular concentrations of various ions. Harrison et al.
found that the intracellular K concentration was decreased by digitalis therapy.66
However, other workers found that digitalis, especially if applied in therapeutic
rather than toxic concentrations, could increase intracellular K. Hajdu and Leonard
suggestedthattheinotropiceffectsofKlossmightbeproducedbyalossofpotassium
from the cell.67 (iv) It was also suggested that cardiac glycosides could affect the
"relaxing factor" of cardiac muscle. This relaxing factor is now known to be the
61 Q. Loewi, 'Uber den Zusammenhang zwischen Digitalis- und Kalziumwirkung',
Arch.exp.Path.Pharmac., 1918, 83: 366.
62 Cushny, op. cit., note 23 above p. 93.
63 A. Wollenberger, 'The energy metabolism ofthe failingheart and the metabolic action ofthe cardiac
glycosides', Pharmacol.Rev., 1949, 1: 311-352.
" J.S. Robb and S. Mallov, 'Effect of ouabain on actomyosin threads', J.Pharmacol.exp. Ther., 1953,
108: 251-259.
65 P. Waser, 'Cardiac glycosides and actomyosin', Proc. 1st Internat. Pharmacol. Meeting, 1961, 3:
173-184.
" T.R. Harrison, Failure ofthe circulation, 2nd ed., Baltimore, Md., Williams & Wilkins, 1939.
67 S. Hajdu and E. Leonard, 'The cellular basis ofcardiac glycosidesaction',Pharmacol.Rev., 1959, 11:
173-209.
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uptake of Ca ions into the s.r. Lee et al.68 suggested that this might be affected by
glycosides, although other work has shown contradictory effects of digitalis on it.69
The modern chapter in the history of digitalis owes its origin to three important
breakthroughs. (i) In 1953, Schatzmann showed thatcardiacglycosidesinhibited the
active uptake ofK and extrusion ofNafrom redblood cells.70 The importance ofthis
experiment isthat, in thissimple preparation, digitalis has no effects on metablolism
and therefore the effects on ion movements are not merely secondary to changes of
metabolism. (ii) In 1945, Heilbrun and Wiercinski had shown that intracellular
injection of calcium into skeletal muscle produced contraction.7" Subsequent work
has confirmed that the application of calcium (but not other ions) produces
contraction and, more recently, it has become possible to measure Ca during
contraction in cardiac muscle and show that it rises.72 The record offig. 3 shows that
[Ca2+]i does, indeed, rise during the positive inotropic effects of the digitalis-like
compound strophanthidin. (iii) The link between, on the one hand, the
demonstration that digitalis inhibited Na and K movements and, on the other, that
changes of intracellular Ca rather than Na or K were required to affect contraction
was provided by work on the interactions between Na and Ca movements. In 1948,
Wilbrandt and Koller73 found that the force of contraction of the frog heart was
regulated by the ratio of the extracellular Na to Ca concentrations and, ten years
later,thiswasinterpreted asacompetitionbetween Naand Caionsforbindingsiteto
activate contraction.74 A further ten years later, Reuter and Seitz showed that the
efflux of calcium ions from the mammalian heart depended on the presence of
extracellular Na.75 The next year, Bakeretal.76 described an exchange ofNa and Ca
ions across the membrane of squid axon and pointed out that a similar Na-Ca
exchange in cardiac muscle could explain not only the fact that contraction was
increased by decreasing the extracellular Na concentration, but also how a rise of
intracellular Na ([Na]i) resulting from Na-K pump inhibition would act on Na-Ca
exchange to increase intracellular Ca and thence contraction:
digitalis -- inhibit Na-K pump - [Na+]i Na-Ca exchange T [Ca2+]i T tension
6 K.S. Lee, 'Relation ofCaions tothe inotropicand metabolicactions ofcardiacglycosides', in op. cit.,
note 65 above, pp. 185-201.
69 K.S. Lee and W. Klaus, 'The sutcellular basis for the mechanism of inotropic action of cardiac
glycosides', Pharmacol.Rev., 1971, 23: 193-261.
70 H.J. Schatzmann, 'Herzglykoside als Hemmstoffe fur den activen Kalium- und Naturiumtransport
durch die Erythrocytenmembran', Helv. physio. pharmacol. Acta, 1953, 11: 346-354.
71 L.V. Heilbrun and F.J. Wiercinski, 'The action of various cations on muscle protoplasm',
J.cell.comp.Physiol., 1954, 29: 75.
72 D.G. Allen and J.R. Blinks, 'Calcium transients in aequorin-injected frog cardiac muscle', Nature,
1978, 273: 509-513.
7 W. Wilbrandt and H. Koller, 'Die Calciumwirkung am Froschherzen als Funktion des
Tonengleichgewichts zwischen Zellmembran und Umgebung', Helv. Physiol. pharmacol. Acta., 1948,6:
208.
7 H.C. Luttgau and R. Niedergerke, 'The antagonism between Ca and Na ions on the frog's heart',
J.Physiol., 1958, 143:(
5 H. Reuter and H. Seitz, 'The dependence ofcalcium efflux from cardiac muscle on temperature and
ionic composition', ibid., 1968, 195: 451-470.
76 P.F. Baker, M.P. Blaustein, A.L. Hodgkin, and R.A. Steinhardt, 'The influence ofcalcium on sodium
efflux in squid axons', ibid., 1969, 200: 431-458.









Figure 3. The effects of the cardiac glycoside strophanthidin on tension and intracellular calcium
concentration [Ca'l+] in an isolated ferret papillary muscle. The top part of the figure shows the time
course of onset of effects of stropanthidin. The upper trace is a record of the light emitted by the
photoprotein aequorin. An increase oflight emission indicates an increase of[Ca'+]i. The lower trace is
tension(upward deflectioncorresponds toanincrease oftension). The muscle wasstimulated every three
seconds and, attheslowchartspeedused,theincreasesoftensionand[Cal+]t produced bystimulationare
fusedtogether. Thelowerpartofthefigure showsaveraged, expanded recordsfrom the regionsindicated
above. Note that strophanthidin increasesboth[Ca'+]iand tension. (From D.G. AllenandC.H. Orchard,
J. Mol. cell. Cardiol, 1984, 16: 117-128.)
Work in the period since 1969 has concentrated on testing this theory of Na-K
pump inhibition. The theory has received support from the demonstration that
manoeuvres which increase the intracellular Na concentration do increase the force
ofcontraction of the heart." Objectors to this so-called sodium-lag theory question
whether, at the concentrations used therapeutically, glycosides inhibit the Na-K
pump. Uncertainty arises because of reports that, at low concentrations, the
glycosides canstimulate the pump. Stimulation ofthe Na-K pump has been reported
77 D.A. Eisner, W.J. Lederer, and R.D. Vaughan-Jones, 'The dependence of sodium pumping and
tension on intracellular sodium activity in voltage-clamped sheep Purkinje fibres', ibid., 1981, 317:
163-187.
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as long ago as 1961 by Wilbrandt and Weiss, who found that, although high
concentrations of cardiac glycosides inhibited, low concentrations increased the
transport of Na ions across frog skin.78 Subsequently, Repke found that low
concentrations ofglycosides could stimulate a purified Na-K ATPase preparation.79
Although this stimulatory effect has been often reported, there has been
considerable reluctance to accept it. There are probably two reasons for this. First,
the stimulatory effect is not always seen and, even in preparations in which it can be
demonstrated sometimes, it is a labile phenomenon.80 In contrast, the inhibitory
effect (of high concentrations) is perfectly reproducible. Another unresolved
question is whether the reported stimulation is a direct effect on the Na-K pump or,
alternatively, isproducedby anaction oftheglycoside on nerveterminalswhichthen
producesa release ofnoradrenaline which canindirectlystimulate the Na-Kpump.8'
Second, even ifstimulation could be shown consistently, there is no explanation for
how aNa-Kpumpstimulation couldincrease theforce ofcontraction. Indeed, onthe
modelpresented above, pumpstimulation wouldbe expected todecreaseratherthan
to increase the force. It has therefore been suggested (see Noble82 for areview) that
the inotropic effect ofcardiac glycosides may depend on some other action than the
direct effect on the Na-K pump rateToconfuse the issuefurther, we would note that
recent work (Isenberg) claims that intracellular injection of cardiac glycosides
increases theforce ofcontraction.83 Since binding ofcardiacglycosidestothesodium
pump occurs at the outside ofthe cell, this observation would suggest that the Na-K
pump may not be directly involved in the inotropic action.
A lot ofrecent work hasbeen directed toinvestigating theideathat there may be a
naturally occurring endogenous cardiacglycoside in man. It hasbeen reported that a
substance isolated from plasma can inhibit the Na-K pump and that thissubstance is
present at greater concentrations in plasma from hypertensive patients. It has been
suggested that such an endogenous cardiac glycoside would increase the contraction
of arterial smooth muscle and thence increase blood pressure. It has therefore been
suggested as one of the causes of essential hypertension.84
We would end this review by quoting from Glynn who, in 1969, summarized the
problem in research on the mechanism of action of cardiac glycosides as follows:
"The pharmacologist confronted with the actions ofcardiac glycosides is a little like
the medieval philosopher confronted with the universe. Many things happen and
7 W. Wilbrandt and E.M. Weiss, 'Antagonism between cardiac glycosides and corticosteroids in the
frog's skin potential', Arzneimittelforsch., 1960, 10: 409.
79 K. Repke, 'Metabolism of cardiac glycosides', in op. cit., note 65 above, pp. 47-73.
80 R.F. Palmer, K.C. Lasseter, and S.L. Melvin, 'Stimulation of Na+ and K+ dependent adenosine
triphosphate by ouabain', Arch.Biochem., 1966, 113: 629.
8 T.J. Hougen, N. Spicer, and T.W. Smith, 'Stimulation of monovalent cation active transport by low
concentrations of cardiac glycosides. Role of catecholamines', J.clin.Invest., 1981, 68: 1207-1214.
" D. Noble, 'Mechanism ofaction oftherapeutic levels ofcardiacglycosides', Cardiovasc.Res, 1980, 9:
495-541.
8 G. Isenberg, 'Contractility of isolated bovine myocytes is enhanced by intracellular injection of
cardioactive glycosides. Evidence for an intracellular mode of action', in E. Erdmann (editor), Cardiac
glycoside receptors and positive inotropy, Darmstadt, Steinkopff, 1984, pp. 56-71.
8 J.M. Hamlyn and M.P. Blaustein, 'Endogenous digitalis-like compounds: putative regulators of the
sodium pump', Trends in neurosciences, 1984, 307-308.
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some things obviously happen as the result of other things, butidentification of the
first cause turns out to be rather difficult".85 This statement is still clearly relevant
today.
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